Pinheiro Neto advised on the transaction in which Sanofi completed the sale to CD&R of a 50% controlling stake in Opella, retaining a 48.2% stake and Bpifrance holding 1.8%. The transaction had a net cash value
Pinheiro Neto advised on the transaction in which Sanofi completed the sale to CD&R of a 50% controlling stake in Opella, retaining a 48.2% stake and Bpifrance holding 1.8%. The transaction had a net cash value